Substance
LINTUZUMAB SATETRAXETAN AC-225
Global reference: every product and company linked to this substance.
- cas: 2209911-94-2
- ncit: C82414
- unii: V860J30J9N
ACTIMAB-A · ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN · Actinium (225Ac) lintuzumab satetraxetan [WHO-DD] · actinium (²²⁵Ac) lintuzumab satetraxetan [INN] · SGN-33 AC-225
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.